Lundbeck says cancer drug approved in Canada
COPENHAGEN Aug 28 (Reuters) - Danish pharmaceutical group Lundbeck said on Tuesday it had received approval from Health Canada for its cancer treatment Treanda which is used to treat two common types of cancer including lymphocytic leukaemia.
Lundbeck said the move would substantially strengthen the group's growth outlook, but kept its full-year guidance intact.
It said it expected Treanda would be available to physicians and patients in Canada during September.
(Reporting by Mette Fraende; Editing by Dan Lalor)
- Tweet this
- Share this
- Digg this
- UPDATE 3-U.S. regulator questions Verizon plan to slow data speeds for some
- Argentina credit story grows murkier as talks collapse
- U.S. man sues soccer star Cristiano Ronaldo over CR7 trademark
- Best Buy CEO says tablet sales are "crashing" - Re/code
- Kerry presses India on global trade deal as deadline looms